Virax Biolabs Group Ltd. Class A's total assets for Q2 2026 were $5.72M, a decrease of -11.08% from the previous quarter. VRAX total liabilities were $641.52K for the fiscal quarter, a -33.50% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.